Cargando…
Neostigmine for non-mild acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials
Background: The therapeutic value of neostigmine as a prokinetic drug in acute pancreatitis (AP), especially in non-mild AP, including moderately severe and severe AP remains controversial. This meta-analysis aimed to investigate the efficacy of neostigmine treatment in patients with non-mild AP. Me...
Autores principales: | He, Kun, Wang, Yabing, Li, Jianing, Bai, Xiaoyin, Yang, Zihan, Han, Xianlin, Wu, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011075/ https://www.ncbi.nlm.nih.gov/pubmed/36925642 http://dx.doi.org/10.3389/fphar.2023.1131974 |
Ejemplares similares
-
Neostigmine for the treatment of acute pancreatitis: a protocol for a systematic review and meta-analysis
por: He, Kun, et al.
Publicado: (2023) -
Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis
por: He, Wenhua, et al.
Publicado: (2022) -
Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial
por: El-Tamalawy, Mona M., et al.
Publicado: (2022) -
New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength
por: Si, Shangkun, et al.
Publicado: (2023) -
Supplemented Use of Pre-, Pro-, and Synbiotics in Severe Acute Pancreatitis: An Updated Systematic Review and Meta-Analysis of 13 Randomized Controlled Trials
por: Tian, Xu, et al.
Publicado: (2018)